Pharma Coding – FOSRx To Acquire Louisiana-Based F.A.S.T.

MLT CreativeIndustries

Recently it was revealed in a news release that Cumberland, MD based FOSRx (Factor One Source Pharmacy) would acquire F.A.S.T. (Fast Access Specialty Therapeutics) based in Metairie, LA through a combination of cash and stock. FOSRx, or Factor Once Source Pharmacy serves patients across the U.S., providing specialty prescriptions for those requiring specialized management of medications for chronic medical conditions. …

Pharma News – Zydus Cadila Buys Six Brands From Merck India

MLT CreativeNews

Recently in pharma news, Zydus Cadila announced the Ahmadabad-based company has acquired six brands from Merck India, also referred to as MSD outside of the U.S. and Canada, through its wholly-owned subsidiary Zydus Healthcare Ltd. News reports do not indicate how much Zydus Cadila paid for these brands, which fall in the wound management therapy, cardiovascular, and men and women’s …

Pharma Coding – Corporation Lands Contract To Build Novo Nordisk Plant

MLT CreativeIndustries

Recently it was announced that Fluor Corporation of Irving, TX landed a $1.2 billion contract to design and build the $2 billion manufacturing facility for Novo Nordisk‘s diabetes API (Active Pharmaceutical Ingredient) in North Carolina. News reports reveal the world-class facility designed to provide diabetes patients with modern treatments is the largest investment in a life sciences facility in the …

Pharma Coding – Novo Nordisk Pledges To Put A Lid On Price Increases

MLT CreativeIndustries

Recently it was announced by Novo Nordisk U.S.‘ EVP, Jakob Riis, that the Denmark-based company pledges to limit increases in drug prices in the U.S., acknowledging the difficulty many patients with diabetes have when it comes to the ability to afford their medications. Riis said in an article posted on the Novo Nordisk A/S website that future increases in price …

Fidia Pharmaceutical Introduces New Packaging For Hyalo Gyn®

MLT CreativeIndustry News

Recently it was announced that a global leader in hyaluronic acid products, Fidia Farmaceutical S.p.a. and its wholly owned subsidiary Fidia Pharma USA Inc., introduced new product packaging for its HYALO GYN® vaginal hydrating gel, while the formulation of the product would remain the same. The company specializes in R & D and manufacturing of products based on HA, or …